MEDFORD, N.Y. , Sept. 24, 2013 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care diagnostic tests for infectious diseases, announces that Lawrence A. Siebert , Chief Executive Officer, will present at the 4 th Annual Craig-Hallum Alpha Select Conference to be
MEDFORD, N.Y. , Sept. 5, 2013 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care diagnostic tests for infectious diseases, today announced that Lawrence A. Siebert has stated his intention to retire from his positions as chief executive officer and president of
MEDFORD, N.Y. , June 27, 2013 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI) a leader in point-of-care ("POC") diagnostic tests for infectious diseases, announced today that it will join the Russell Global Index when Russell Investments reconstitutes its comprehensive set of U.S.
MEDFORD, N.Y. , May 23, 2013 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI) a leader in point-of-care ("POC") diagnostic tests for infectious diseases, announced today that it has been awarded a cooperative research agreement with a U.S. government agency for up to $750,000 for an
MEDFORD, N.Y., May 22, 2013 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care diagnostic tests, announced today the appointment of Sharon Klugewicz as its Chief Operating Officer, effective May 22, 2013. In this newly created position, Ms.
Print Page